Global eye care company Alcon has announced earlier this week the latest addition of ALCAINE® (proparacaine hydrochloride ophthalmic solution, USP) 0.5% 15mL to its Procedural Eye Drops portfolio. ALCAINE® Solution 0.5% 15mL, currently the only branded proparacaine available, is a topical local anesthetic indicated for corneal anesthesia of short duration, and for short corneal and conjunctival procedures. Alcon’s Procedural Eye Drops portfolio is made up of mydriatic, cycloplegic, diagnostic and anesthetic products.
ALCAINE® Solution 0.5% 15mL is a topical local anesthetic indicated for corneal anesthesia of short duration, such as during tonometry or gonioscopy, and for the removal of corneal foreign bodies; and for short corneal and conjunctival procedures. Before surgeries or as part of other treatments, ALCAINE® Solution 0.5% 15mL may be used as follows:
- For the removal of foreign bodies and sutures, and for tonometry: use 1 to 2 drops (in single installations) in each eye before operating.
- For short corneal and conjunctival procedures: use 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.
“We strive to offer the most complete line of high-quality ophthalmic products to better serve our customers,” said Brian O’Neal, Head of Marketing, US Surgical, Alcon. “For decades, ALCAINE® Solution 0.5% 15mL has been a trusted solution for surgical and clinical ophthalmic procedures. We hope by offering this product directly from Alcon we will continue to meet the ongoing needs of patients and eye care professionals.”
Read the full news release from Alcon.